Arcus Biosciences is a 'Buy' with strong trial results, robust pipeline, and key phase 3 news coming. Click here to read an analysis of RCUS stock now.

Agenus Inc. (“Agenus”) (Nasdaq: AGEN ), a leader in immuno-oncology, will host a virtual Stakeholder Briefing on Tuesday, October 21, 2025, at 4:00 p.m. ET. The webcast will f ...

India's youngest billionaires are changing the nation's economy. These entrepreneurs, aged 31 and under, are making their ...

The USAN, consisting of members from the Food and Drug Administration (FDA), American Medical Association (AMA), United States Pharmacopeia (USP) and the American Pharmacists Association (APhA), is ...

Highland Copper Company Inc. (TSXV: HI; OTCQB: HDRSF) (“Highland” or the “Company”) has successfully completed Phase 1 ...

Patients treated with ulixacaltamide in the parallel-group study (Study 1) showed a mean improvement from baseline in the Modified Activities of ...

Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.